Carlen Reyes

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

M. Schuemie, G. N. Norén, D. Sartori, 2023, Drug Safety.

Smoking and Alcohol Intake but Not Muscle Strength in Young Men Increase Fracture Risk at Middle Age: A Cohort Study Linked to the Swedish National Patient Registry

M. Englund, B. Rosengren, D. Prieto-Alhambra, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Time trends in the incidence of cardiovascular disease, hypertension and diabetes by sex and socioeconomic status in Catalonia, Spain: a population-based cohort study

H. Freisling, T. Duarte-Salles, C. Reyes, 2023, BMJ Open.

Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study

M. Suchard, M. Schuemie, G. Hripcsak, 2024, medRxiv.

Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research

P. Rijnbeek, E. Burn, T. Duarte-Salles, 2023, Clinical epidemiology.

Real-world treatment trajectories of adults with newly diagnosed asthma or COPD

R. Kolde, E. Burn, A. Markus, 2024, BMJ open respiratory research.

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries

E. Burn, T. Duarte-Salles, A. Delmestri, 2022, Pharmacoepidemiology and drug safety.

The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications

R. Kolde, A. Uusküla, T. Duarte-Salles, 2024, Heart.

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM

M. Suchard, M. Schuemie, G. Hripcsak, 2023, BMJ medicine.

Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM.

M. Suchard, A. Ostropolets, H. Krumholz, 2024, Journal of the American College of Cardiology.